A mass on the liver can be anything from a completely harmless fluid-filled cyst to a primary cancer, a secondary deposit from cancer elsewhere in the body, an abscess caused by bacteria, or even a patch of uneven fat distribution that only looks like a mass on a scan. The overwhelming majority of liver lesions found by accident in people without known liver disease or cancer history turn out to be benign, with more than 95 percent of incidental findings in low-risk patients under 40 falling into that category.1PubMed Central. WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver Still, the word “mass” on an imaging report understandably triggers alarm, and the range of possibilities is wide enough that understanding the landscape matters.
Hemangiomas, the Most Common Benign Liver Mass
If you are told you have a liver mass and you have no history of cancer or chronic liver disease, the single most likely diagnosis is a hemangioma. These are tangles of blood vessels that form a soft, spongy growth inside the liver. They are the most common benign liver tumor, and they are almost always discovered by accident during an imaging study done for some other reason.2PubMed Central. Hepatic hemangioma: What internists need to know Most hemangiomas are small, cause no symptoms, and never need treatment. Doctors can usually identify them with confidence on ultrasound, CT, or MRI because they have a recognizable pattern of filling with contrast dye from the edges inward.
The catch is that not all hemangiomas look textbook. Atypical hemangiomas can be difficult to tell apart from more worrisome lesions, including metastatic deposits and hepatocellular carcinoma.3Clinical Imaging. The humbling hemangioma: uncommon CT and MRI imaging features and mimickers of hepatic hemangiomas When the imaging is ambiguous, doctors may recommend a second type of scan or, in rare cases, a biopsy to settle the question. But the vast majority of hemangiomas are straightforward to diagnose and require nothing more than reassurance.
Focal Nodular Hyperplasia and Hepatic Adenoma
Two other benign solid liver masses show up frequently in younger adults, especially women. Focal nodular hyperplasia (FNH) is a cluster of normal-looking liver cells organized around a central scar of fibrous tissue. It does not become cancerous and rarely causes symptoms. Hepatic adenoma (HA) is a true benign tumor of liver cells, and while it is less common than FNH, it carries a small risk of bleeding or, in certain subtypes, malignant transformation. Both have been linked to oral contraceptive use.4Annals of Hepatology. Focal nodular hyperplasia and hepatic adenoma: A Review
The relationship between FNH and estrogen has been debated. Many experts have questioned whether hormones truly drive FNH growth, but case reports document instances where FNH enlarged in women with high estrogen levels, suggesting at least a subset of these lesions are hormone-sensitive.5PubMed Central. Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth? In practice, doctors tend to monitor FNH conservatively and reserve surgery for the rare cases that grow large or cause pain. Hepatic adenomas get more attention because of the bleeding risk, and women who are diagnosed with one are generally advised to stop hormonal contraceptives.
Simple Cysts and Polycystic Liver Disease
Liver cysts are among the most common incidental findings in imaging. These thin-walled, fluid-filled pockets affect roughly 5 to 10 percent of the general population.6PubMed Central. Complications arising in simple and polycystic liver cysts A simple cyst is usually easy to identify on ultrasound: it appears dark, round, and featureless. The vast majority cause no symptoms and require no treatment. About 5 percent of people with liver cysts eventually develop symptoms or complications, which can include pain from a large cyst pressing on surrounding tissue, infection, or bleeding into the cyst.
Polycystic liver disease is a different entity entirely. In this condition, dozens to hundreds of cysts develop throughout the liver. It occurs mainly in the setting of inherited conditions, and in advanced stages the liver can become massively enlarged, causing abdominal pain, distension, and compression of nearby organs.7PubMed Central. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management If imaging shows numerous cysts rather than one or two, doctors will usually investigate for an underlying genetic condition and assess kidney function as well, since polycystic kidney disease frequently accompanies the liver form.
Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, meaning it starts in the liver cells themselves. It is the diagnosis people fear most when they hear about a liver mass, and it is most strongly associated with chronic liver disease: cirrhosis from any cause, chronic hepatitis B or C infection, heavy alcohol use, and increasingly, nonalcoholic fatty liver disease (NAFLD). A large meta-analysis found that obesity nearly doubled the risk of HCC, and NAFLD raised the risk by a similar margin.8PubMed Central. Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
Among people with NAFLD who have progressed to cirrhosis, the annual rate of developing HCC is considerably higher than in those without cirrhosis. But HCC does not always require cirrhosis as a prerequisite. One study of NAFLD patients with HCC found that about 20 percent had no evidence of cirrhosis in their medical records.9Gastroenterology. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease The risk is higher in men, increases with age, and climbs further with worsening fibrosis, insulin resistance, and diabetes.10Metabolism. Nonalcoholic fatty liver disease and hepatocellular carcinoma This is why people with known cirrhosis or chronic hepatitis B are typically enrolled in surveillance programs that include liver ultrasound every six months.
Cholangiocarcinoma
Cholangiocarcinoma is a cancer of the bile ducts, and when it arises inside the liver, it is called intrahepatic cholangiocarcinoma. It is less common than HCC but can appear on imaging as a liver mass and is sometimes initially confused with it. The risk factors overlap somewhat with HCC but have their own distinct profile. Chronic inflammatory conditions of the bile ducts, particularly primary sclerosing cholangitis, are strongly associated. So are parasitic infections of the biliary tract (liver flukes), stones within the liver’s bile ducts, and congenital abnormalities of the biliary tree.11PubMed Central. Epidemiology and risk factors: intrahepatic cholangiocarcinoma Viral hepatitis, cirrhosis, diabetes, obesity, alcohol, and smoking have all been identified as additional potential risk factors, though the strength of the link varies.12PubMed Central. Risk factors for cholangiocarcinoma
In short, any chronic process that causes inflammation and scarring of the bile ducts or liver tissue raises the odds of cholangiocarcinoma.13Cancer Letters. Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management Because intrahepatic cholangiocarcinoma behaves differently from HCC and responds to different treatments, getting the distinction right matters for planning care.
Metastatic Disease
The liver is one of the organs most commonly targeted by cancers that started somewhere else. In fact, metastatic liver disease is far more common than primary liver cancer in Western countries. The liver’s enormous blood supply makes it a natural landing spot for tumor cells shed by cancers of the colon, pancreas, breast, lung, stomach, and many other sites. A new liver mass in someone with a known cancer history is treated as suspicious for metastasis until proven otherwise. Multiple new lesions are particularly concerning, though a solitary metastasis is also possible.
Even in patients being treated for cancer, not every liver lesion that appears on a scan turns out to be malignant. A benign hemangioma or cyst can show up at the same time as real metastatic disease. That is why doctors use contrast-enhanced imaging to characterize each lesion individually rather than assuming every spot is the same. When a liver mass in a cancer patient remains uncertain after CT and MRI, contrast-enhanced ultrasound or biopsy may be the next step.14PubMed. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
Liver Abscesses
An abscess is a walled-off pocket of infection, and in the liver it can appear as a mass on imaging. Bacterial liver abscesses usually present with fever, chills, and right upper abdominal pain. The most common culprit globally is Klebsiella pneumoniae, which was identified in roughly 40 to 80 percent of culture-positive cases depending on the geographic region studied.15PubMed Central. Etiology and clinical manifestations of bacterial liver abscess In Southeast Asia, Klebsiella dominates and is closely associated with diabetes. In Central Europe, E. coli and Streptococcus are more common, and the abscess is more likely to stem from a biliary problem or an underlying malignancy.16PubMed Central. Pyogenic liver abscess: differences in etiology and treatment in Southeast Asia and Central Europe Most bacterial abscesses are solitary and located in the right lobe of the liver.17Clinical Infectious Diseases. Pyogenic Liver Abscess: Recent Trends in Etiology and Mortality
Treatment usually involves antibiotics plus drainage, either through a needle inserted through the skin or through a surgically placed drain. Unlike most other liver masses, a bacterial abscess tends to declare itself quickly through symptoms rather than sitting silently on a scan.
Parasitic Cysts
In parts of the world where sheep and cattle farming are common, a tapeworm called Echinococcus can cause cysts in the liver known as hydatid cysts. These develop slowly, sometimes over years, and can grow quite large before causing symptoms. Some remain clinically silent for an entire lifetime.18PubMed Central. Hepatic Echinococcal Cysts: A Review On imaging, hydatid cysts have characteristic layered or septated appearances that help distinguish them from simple cysts, though small or early-stage cysts can look similar. The disease carries a high risk of recurrence even after treatment, and rupture of a hydatid cyst can cause a severe allergic reaction.19PubMed Central. Hydatid Cyst or Echinococcosis: A Comprehensive Review of Transmission, Clinical Manifestations, Diagnosis, and Multidisciplinary Treatment In regions where echinococcosis is not endemic, it is an uncommon diagnosis, but travel history or immigration from endemic areas is always worth mentioning to your doctor when a liver cyst is found.
Pseudotumors That Are Not Really Tumors at All
Sometimes what looks like a mass on a scan is not a growth at all. Fatty liver disease can distribute unevenly, leaving patches of normal liver tissue surrounded by fatty tissue, or patches of fat surrounded by normal tissue. These areas of focal fatty change or focal fatty sparing can look alarmingly like tumors or metastases on ultrasound or CT.20PubMed Central. Multiple liver pseudotumors due to hepatic steatosis and fatty sparing: A non-invasive imaging approach They tend to appear in predictable locations, such as near the falciform ligament or adjacent to the gallbladder, which gives radiologists a clue. A special MRI technique that compares how fat and water behave in tissue can confirm the diagnosis and prevent unnecessary biopsy or treatment.21PubMed. Hepatic pseudotumor due to nodular fatty sparing: the diagnostic role of opposed-phase MRI If you have been told you have fatty liver and then a “mass” is spotted, this is one of the first possibilities your doctor should consider.
How Doctors Figure Out What a Liver Mass Is
The first tool is almost always imaging. A liver mass might be spotted on an ultrasound ordered for something unrelated, and then the characterization work begins. CT and MRI with contrast are the workhorses for telling benign lesions apart from malignant ones. The liver has a unique dual blood supply, receiving blood from both the hepatic artery and the portal vein, and different types of masses light up and wash out at different speeds during the phases of a contrast-enhanced scan.22PubMed Central. Liver masses: a clinical, radiologic, and pathologic perspective Radiologists use these patterns to narrow the possibilities.
For patients at risk for HCC, a standardized system called LI-RADS (Liver Imaging Reporting and Data System) helps radiologists categorize each observation on a scale from definitely benign to definitely HCC, with categories in between for indeterminate findings.23PubMed Central. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients In low-risk patients, contrast-enhanced ultrasound is increasingly used as a first-line contrast imaging step because it avoids radiation and performs comparably to MRI for telling benign from malignant lesions. A key warning sign on contrast ultrasound is a lesion that becomes darker than the surrounding liver in the late phase of the exam, a pattern characteristic of malignancy.1PubMed Central. WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver
Blood Markers
Blood tests alone cannot diagnose a liver mass, but certain tumor markers help narrow the field. Alpha-fetoprotein (AFP) is the best-known blood marker for liver cancer. As a standalone test it has a sensitivity of about 63 percent for HCC, meaning it misses roughly a third of cases, though its specificity is higher.24PubMed Central. Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma AFP performs poorly for small or early-stage liver cancers, which is precisely where early detection matters most.25PubMed Central. Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer Carcinoembryonic antigen (CEA) is another marker, used mainly to monitor colorectal cancer, but it can rise in a variety of malignant and benign conditions and is not specific enough to diagnose a liver mass on its own.26PubMed Central. Carcinoembryonic antigen in the diagnosis, treatment, and follow-up of focal liver lesions In practice, blood markers supplement imaging rather than replace it.
When a Biopsy Is Needed
Most benign liver masses can be identified on imaging alone, and biopsies are reserved for cases where the diagnosis remains uncertain and the answer would change treatment. In patients with known cancer, a biopsy of a liver lesion may be needed to confirm metastasis and guide drug selection. One concern that sometimes comes up is needle-tract seeding, where tumor cells spread along the path of the biopsy needle. A large meta-analysis estimated this risk at about 1 percent overall.27PubMed Central. Risk of tumour seeding in patients with liver lesions undergoing biopsy with or without concurrent ablation: meta-analysis Using a coaxial technique, where the outer needle stays in place and shields the tract while the inner needle takes samples, appears to reduce both the seeding rate and the overall complication rate.28PubMed Central. Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk One study using coaxial cutting needles reported zero seeding events, with the authors noting this had particular importance for patients with early-stage HCC being considered for transplant.29PubMed. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique
How Risk Profile Shapes the Workup
The single most important factor in determining how aggressively a liver mass is investigated is the patient’s background. A 30-year-old woman with no liver disease history who has a small bright spot on ultrasound is in a completely different situation from a 65-year-old man with hepatitis C and cirrhosis who has the same finding. For the first patient, that spot is overwhelmingly likely to be a hemangioma or FNH, and follow-up imaging alone may be enough. For the second, even a small new nodule triggers a protocol specifically designed to catch HCC early, potentially including multiphasic CT or MRI with LI-RADS scoring and possible biopsy.
Patients with an active or recent cancer are similarly treated with a higher index of suspicion. Each new liver lesion found during cancer surveillance is initially assumed to be potentially malignant until proven otherwise, and every effort is made to confirm or rule out metastasis.1PubMed Central. WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver The practical takeaway: when your doctor recommends additional imaging or a biopsy for a liver mass, that recommendation is calibrated to your personal risk, not to the appearance of the mass in isolation.
Treatment Depends Entirely on the Diagnosis
The management of a liver mass ranges from doing nothing at all to major surgery. Simple cysts and typical hemangiomas are left alone. Hepatic adenomas may be monitored or removed depending on size, subtype, and whether hormonal contraceptives can be discontinued. Abscesses require drainage and antibiotics. For malignant lesions, options include surgical removal, liver transplant for eligible HCC patients, percutaneous ablation (using heat or cold to destroy the tumor through the skin), and systemic therapies like chemotherapy or targeted drugs. Ablation is currently considered a first-line treatment for very early and early-stage HCC, and a second-line option for colorectal cancer metastases in the liver.30PubMed Central. Liver Ablation: Best Practice
Liver Masses in Children
Pediatric liver masses deserve a separate mention because the spectrum of possibilities is different from adults. During the first year of life, most liver tumors in infants are benign, with hemangiomas being especially common. However, some of these benign-looking lesions can cause complications such as heart failure or thyroid problems due to the tumor’s vascular activity, and they may need treatment rather than simple observation.31PubMed Central. Differential diagnosis and management of liver tumors in infants
Hepatoblastoma, the most common primary liver cancer in young children, peaks between six months and three years of age. Over 90 percent of cases are diagnosed before age five, and it is more common in boys. Symptoms are often nonspecific, like a swelling belly or jaundice, and elevated AFP in the blood is a hallmark finding.32PubMed Central. Uncommon liver tumors Case report and literature review This is one setting where AFP is quite useful as a diagnostic marker, in contrast to its limited sensitivity in adult liver cancers. Pediatric liver masses are evaluated differently from those in adults, with age-specific imaging protocols and tumor markers playing a larger role.33PubMed Central. Pediatric Primary Hepatic Tumors: Diagnostic Considerations
The Anxiety of Incidental Findings
Many liver masses are found by accident during a scan ordered for an entirely unrelated reason, and the psychological impact of that discovery is real. Research on people who received incidental findings on abdominal CT scans found that emotional distress was significantly higher in participants whose results required follow-up compared to those whose scans were clear.34PLOS ONE. Incidental findings on non-contrast abdominal computed tomography in an asymptomatic population: Prevalence, economic and health implications People with greater psychological resilience handled the news better, which is not surprising, but the finding underscores that the period between “we found something” and “here is what it is” can be genuinely distressing.
If you find yourself in that waiting period, it helps to know the statistical context. In a healthy person under 40 with no cancer history and no chronic liver condition, the odds overwhelmingly favor a benign diagnosis. Even in older adults, the most common incidental liver findings remain cysts and hemangiomas. The follow-up imaging your doctor orders is not a sign that something is wrong; it is the standard process for characterizing a finding so that everyone can move forward with confidence. If you have risk factors for liver disease, the urgency is appropriate and the surveillance systems are well established, which is a better position to be in than having something undetected.